John Farnam
2018
In 2018, John Farnam earned a total compensation of $1.7M as Former Chief Operating Officer at Kura Oncology.
Compensation breakdown
| Non-Equity Incentive Plan | $92,553 |
|---|---|
| Option Awards | $1,440,640 |
| Salary | $177,500 |
| Other | $6,647 |
| Total | $1,717,340 |
Farnam received $1.4M in option awards, accounting for 84% of the total pay in 2018.
Farnam also received $92.6K in non-equity incentive plan, $177.5K in salary and $6.6K in other compensation.
Rankings
In 2018, John Farnam's compensation ranked 6,495th out of 14,244 executives tracked by ExecPay. In other words, Farnam earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,495 out of 14,244 | 54th |
Division Manufacturing | 2,483 out of 5,765 | 57th |
Major group Chemicals And Allied Products | 925 out of 2,128 | 57th |
Industry group Drugs | 777 out of 1,817 | 57th |
Industry Pharmaceutical Preparations | 605 out of 1,391 | 57th |
Source: SEC filing on April 28, 2020.
Farnam's colleagues
We found three more compensation records of executives who worked with John Farnam at Kura Oncology in 2018.